Frank A. Dinnucci

Proof Diagnostics, Inc. is a company that specializes in providing affordable and accessible COVID-19 molecular testing using CRISPR technology. The company is based in Cambridge, MA. Led by world-renowned molecular biologist Dr. Feng Zhang, the company aims to help communities take control of their health. Proof Diagnostics was founded in 2020 by Feng Zhang, Sid Shenai, Jonathan Gootenberg, Omar Abudayyeh. Sid Shenai has been the CEO since 2020.

Orphan Medical, Inc. develops and markets pharmaceutical and health care products. The company was founded in 1993 and is located in Minnetonka, MN.

Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir.

Paradigm Health, Inc. develops a platform for clinical research. The company is based in New York, NY and has subsidiaries in the United States. The company was founded by Milind Kamkolkar. Kent Thoelke has been the CEO of the company since 2023.

Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya.

Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor.

Leyden Laboratories B.V. is a biotechnology company based in Amsterdam, Netherlands. Leyden Labs aims to protect humanity from known and future viruses by targeting commonalities of viral families. The Dutch company has developed a portfolio of accessible intranasal product candidates that may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The company's energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. Leyden Labs is backed with $200m by blue-chip investors Casdin Capital, GV (formerly Google Ventures), F-Prime Capital, Byers Capital/Brook Byers, SoftBank Investment Advisers, Invus, and Bluebird Ventures. The company was founded in June 2020 by Koenraad Wiedhaup, Jaap Goudsmit, Domenico Valerio, and Ronald H. P. Brus, with Koenraad Wiedhaup serving as the CEO since incorporation.

Geneception, Inc. provides healthcare services. The company is headquartered in Cambridge, MA.

Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA.

Bio Palette Co., Ltd. provides genetic modification services for microbes, therapeutics and agriculture industries. The company was founded by Shoko Murase and Akihiko Kondo on February 21, 2017 and is headquartered in Kobe, Japan.

F-Prime UK Ltd. was founded in 2007 and provides strategy development, market research, investment advisory, and administration support services. The private company is based in London, UK.

American Board of Clinical Pharmacology, Inc. operates as health-related professional association. It provides evaluation for training credentials, preparation and administration for examinations, and register and accredit training programs in clinical pharmacology. in The company is headquartered in San Antonio, TX.

PhytoCeutica, Inc. develops drugs for the treatment of cancer. It focuses on preclinical studies, clinical investigations, and a platform technology to assess botanical quality control and reproducibility. The company was founded by Yale University, Patrick Kung and Dr. Yung-Chi Cheng in 1999 and is headquartered in New Haven. CT.

Theragen, Inc. develops non-invasive therapeutics for the treatment of disease and pain. It is a medical device company to develop effective and safe therapeutic energy technologies applied to the body for healing and pain relief. The company was founded by Kimball Chen, Gary Grenter, Frithjof Fuchs,Alex W. Evans and Jan Andrew Buck and is headquartered in Manassas, VA.

University of Rochester Medical Center operates a medical center which offers healthcare, education and research services. It offers funding in biochemistry, microbiology and immunology, neurology, obstetrics and gynecology, oral biology and musculoskeletal research services. The firm’s departments include AIDS Center, Audiology and Aab Cardiovascular Research Institute. The company was founded by Abraham Flexner and Benjamin Rush Rhees in 1921 and is headquartered in Rochester, NY.

Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.

Part of Takeda Pharmaceutical Co., Ltd., Protein Engineering Corp is a company that screens proteins and peptides used in drug discovery. The company is based in Cambridge, MA. Protein Engineering was acquired by Dyax Corp., part of Takeda Pharmaceutical Co., Ltd. from January 25, 2016 on November 15, 1995.

Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA.

Trevi Management LP (Trevi Health Capital) is a private equity firm founded in 2005 by David Robbins and Andrew Fink. The firm is headquartered in New York with an additional office in London.

NYU Elaine A. & Kenneth G. Langone Medical Center provides health care services. It offers treatments for bone, joint, and muscle disorders; brain and nervous system disorders cancers, tumors and blood disorders; genetic and chromosomal disorders and immune system disorders. The company was founded in 1841 and is headquartered in New York, NY.

Cahill Gordon & Reindel LLP provides legal services. Its practice areas include antitrust, bankruptcy and restructuring, corporate governance and investigations, crisis advisory and management, employee benefits, insurance, intellectual property, litigation, media, real estate, tax, and trusts. The company was founded by Joseph P. Cotton, George S. Franklin, William G. McAdoo and Francis McAdoo in 1919 and is headquartered in New York, NY.

Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA.

Optovue, Inc. develops ophthalmic diagnosis instruments based on the Fourier-Domain OCT technology. Its products include Avanti, RTVue Premier, iFusion, iVue, iCam, iScan, iStand and Networking. The company was founded by Jay Wei and Tom Zhao in 2003 and is headquartered in Fremont, CA.

EasyLap Ltd. is a privately held company dedicated to advancing laparoscopy through its proprietary, patented technologies. Its vision is to enable widespread use of laparoscopy through devices that shorten the learning curve, reduce laparoscopic procedure time, optimize technique, and minimize complications. Easy-Lap's first suite of products, the I-Mesh series, offers an intelligent path to laparoscopic success in hernia repair. The Company is founded by Eldar Samuel, Einat Duvdevany-Fabian, and Fabian Izhak in 2007 and is headquartered in Kfar Truman, Israel.